메뉴 건너뛰기




Volumn 9, Issue 1, 2003, Pages 31-32

Residual disease in DCIS: An excision too far?

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; HUMAN; MAMMOGRAPHY; MASTECTOMY; MEDICAL PRACTICE; NOTE; PREDICTION; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; MINIMAL RESIDUAL DISEASE; PAGET NIPPLE DISEASE; PATHOLOGY; RADIOGRAPHY; REOPERATION; SEGMENTAL MASTECTOMY;

EID: 0038284076     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200301000-00006     Document Type: Note
Times cited : (1)

References (17)
  • 1
    • 0038284078 scopus 로고    scopus 로고
    • Factors associated with residual disease on re-excision in patients with ductal carcinoma in situ of the breast
    • Harris EER, Schultz DJ, Jones HA, Solin LJ et al. Factors associated with residual disease on re-excision in patients with ductal carcinoma in situ of the breast. Cancer J 2003;9:41-47.
    • (2003) Cancer J , vol.9 , pp. 41-47
    • Harris, E.E.R.1    Schultz, D.J.2    Jones, H.A.3    Solin, L.J.4
  • 2
    • 0036756465 scopus 로고    scopus 로고
    • Standards for management of ductal carcinoma in situ of the breast
    • Morrow M, Strom E, Bassett LW et al. Standards for management of ductal carcinoma in situ of the breast. CA Cancer J Clin 2002;52:277-300.
    • (2002) CA Cancer J Clin , vol.52 , pp. 277-300
    • Morrow, M.1    Strom, E.2    Bassett, L.W.3
  • 3
    • 0033549344 scopus 로고    scopus 로고
    • Tamoxifen treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B24 randomized controlled trial
    • Fisher B, Dignam J, Wolmark N et al. Tamoxifen treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B24 randomized controlled trial. Lancet 1999;353:1993-2000.
    • (1999) Lancet , vol.353 , pp. 1993-2000
    • Fisher, B.1    Dignam, J.2    Wolmark, N.3
  • 4
    • 0035871577 scopus 로고    scopus 로고
    • Risk factors for recurrence andmetastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
    • Bijker N, Peterse JL, Duchateau L et al. Risk factors for recurrence andmetastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-2271.
    • (2001) J Clin Oncol , vol.19 , pp. 2263-2271
    • Bijker, N.1    Peterse, J.L.2    Duchateau, L.3
  • 5
    • 0035879447 scopus 로고    scopus 로고
    • Mammographically detected ductal carcinoma in situ of the breast treated with breast conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status
    • Solin LJ, Fourquet A, Vicini FA et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Rad Oncol Biol Phys 2002;50:991-1002.
    • (2002) Int J Rad Oncol Biol Phys , vol.50 , pp. 991-1002
    • Solin, L.J.1    Fourquet, A.2    Vicini, F.A.3
  • 6
    • 0003116235 scopus 로고
    • Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history
    • Hiramatsu H, Bornstein BA, Recht A et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am 1995;1:55-61.
    • (1995) Cancer J Sci Am , vol.1 , pp. 55-61
    • Hiramatsu, H.1    Bornstein, B.A.2    Recht, A.3
  • 7
    • 0038649915 scopus 로고    scopus 로고
    • Breast conserving surgery plus radiation therapy in ductal carcinoma in situ: The Institut Curie experience
    • Silverstein MJ, ed. Philadelphia: LippincottWilliams & Wilkins
    • Fourquet A, Sigal-Zafrani B, Clough KB. Breast conserving surgery plus radiation therapy in ductal carcinoma in situ: The Institut Curie experience. In: Silverstein MJ, ed. Ductal Carcinoma In Situ of the Breast, 2nd ed. Philadelphia: LippincottWilliams & Wilkins, 2002:367-372.
    • (2002) Ductal Carcinoma In Situ of the Breast, 2nd Ed. , pp. 367-372
    • Fourquet, A.1    Sigal-Zafrani, B.2    Clough, K.B.3
  • 8
    • 0035165230 scopus 로고    scopus 로고
    • Extent ofmargin width required in breast conserving surgery for ductal carcinoma in situ
    • Chan KC, Knox WF, Sinha G et al. Extent ofmargin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 2001;91:9-16.
    • (2001) Cancer , vol.91 , pp. 9-16
    • Chan, K.C.1    Knox, W.F.2    Sinha, G.3
  • 9
    • 0021883671 scopus 로고
    • Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast conserving treatment
    • Holland R, Veling S, Mravunac M. et al. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving treatment. Cancer 1985;56:979-986.
    • (1985) Cancer , vol.56 , pp. 979-986
    • Holland, R.1    Veling, S.2    Mravunac, M.3
  • 10
    • 0031941704 scopus 로고    scopus 로고
    • Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B17
    • Fisher B, Dignam J, Wolmark N et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast And Bowel Project B17. J Clin Oncol 1998;16:441-452.
    • (1998) J Clin Oncol , vol.16 , pp. 441-452
    • Fisher, B.1    Dignam, J.2    Wolmark, N.3
  • 11
    • 0028111471 scopus 로고
    • Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications
    • Faverly DRG, Burgers L, Bult P et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-198.
    • (1994) Semin Diagn Pathol , vol.11 , pp. 193-198
    • Faverly, D.R.G.1    Burgers, L.2    Bult, P.3
  • 12
    • 0032894772 scopus 로고    scopus 로고
    • Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ
    • Ratanawichitrasin A, Rybicki LA, Steiger E et al. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg 1999;188:17-21.
    • (1999) J Am Coll Surg , vol.188 , pp. 17-21
    • Ratanawichitrasin, A.1    Rybicki, L.A.2    Steiger, E.3
  • 13
    • 0030824090 scopus 로고    scopus 로고
    • Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease
    • Cheng L, Al-Kaisi NK, Gordon NH et al. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997;89:1356-1360.
    • (1997) J Natl Cancer Inst , vol.89 , pp. 1356-1360
    • Cheng, L.1    Al-Kaisi, N.K.2    Gordon, N.H.3
  • 14
    • 0028336689 scopus 로고
    • Can intraductal breast carcinoma be completely excised by local excision? Clinical and pathologic predictors
    • Silverstein MJ, Gierson ED, Colburn WJ et al. Can intraductal breast carcinoma be completely excised by local excision? Clinical and pathologic predictors. Cancer 1994;73:2985-2989.
    • (1994) Cancer , vol.73 , pp. 2985-2989
    • Silverstein, M.J.1    Gierson, E.D.2    Colburn, W.J.3
  • 15
    • 0036534309 scopus 로고    scopus 로고
    • The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast
    • Neuschatz AC, DiPetrillo T, Steinhoff M et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002;94:1917-1924.
    • (2002) Cancer , vol.94 , pp. 1917-1924
    • Neuschatz, A.C.1    DiPetrillo, T.2    Steinhoff, M.3
  • 16
    • 0033776196 scopus 로고    scopus 로고
    • Postexcision mammography is indicated after resection of ductal carcinoma in situ of the breast
    • Waddell BE, Stomper PC, DeFazio JL et al. Postexcision mammography is indicated after resection of ductal carcinoma in situ of the breast. Ann Surg Oncol 2000;7:665-668.
    • (2000) Ann Surg Oncol , vol.7 , pp. 665-668
    • Waddell, B.E.1    Stomper, P.C.2    DeFazio, J.L.3
  • 17
    • 0034790174 scopus 로고    scopus 로고
    • A comparison of ink-and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins
    • Gibson GR, Lesnikowski BA, Yoo J et al. A comparison of ink-and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol 2001;8:693-704.
    • (2001) Ann Surg Oncol , vol.8 , pp. 693-704
    • Gibson, G.R.1    Lesnikowski, B.A.2    Yoo, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.